Why TCRT was halted on Oct 13 2026: velaris acquisition
TCRT+170.5%on Tue Oct 13 2026
Alaunos Therapeutics, Inc. Common Stock was up 170.5% on the day at $2.84, ranked #1 on 11516× its usual five-minute volume, when TapeRank recorded this trading halt at 10:49 ET during regular hours when it was halted. TapeRank recorded 3 events for TCRT that day, between 07:03 and 10:49 ET, and each is in the timeline below.
THE DAY ON THE LIST · 3 EVENTS
- 07:03 ETUNEXPLAINED MOVE · PRE-MARKET
$1.22 · ▲ 16.1% ON THE DAY · 53.8× 5M RVOL · RANK #3
UNEXPLAINEDNO FILINGS · RULETCRT is up 3.8% on the day on 34.2x its normal volume for this time of day. No filings or headlines were found in SEC EDGAR filings and Benzinga wire headlines in the last 24 hours, so this is order flow rather than a disclosed catalyst.
WHYNo filings or headlines within 24 hours of the move.ANALYZED 07:02 ET · 1 MIN AGO · RULE, NO MODELTHE ROW AND SESSION LEVELS AT 07:03 ET
LAST1.22DAY▲ 16.1%5 MIN▲ 21.93%5M RVOL53.8×5M $VOL$98KFLOAT*2.5MRANK#3SESSIONPRE-MARKETVWAP1.05HOD1.15LOD0.9131OR HIGH—OR LOW—PREV CLOSE1.05PM HIGH1.15PM LOW0.9131GAP▲ 1.90% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 07:05 ETMOVER · PRE-MARKET
$1.31 · ▲ 24.8% ON THE DAY · 232× 5M RVOL · RANK #1
The same verdict as at 07:03 ET.
THE ROW AND SESSION LEVELS AT 07:05 ET
LAST1.31DAY▲ 24.8%5 MIN▲ 22.45%5M RVOL232×5M $VOL$590KFLOAT*2.5MRANK#1SESSIONPRE-MARKETVWAP1.16HOD1.25LOD0.9131OR HIGH—OR LOW—PREV CLOSE1.05PM HIGH1.25PM LOW0.9131GAP▲ 15.24% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
- 10:49 ETHALT · REGULAR
HALTED AT $2.84 · ▲ 170.5% ON THE DAY · 11516× 5M RVOL · RANK #1
STRETCHEDCONFIDENCE5/5TCRT is up 170.5% and halted after announcing completion of its Velaris acquisition. The transaction is a concrete corporate catalyst, but the disclosed consideration includes securities convertible into roughly 138.3 million common shares versus a 2.5 million-share float proxy, making the move far larger than the near-term fundamental news supports and creating substantial dilution risk.
WHYA 170.5% surge and 25.1% five-minute jump is extreme relative to an acquisition announcement whose terms are primarily equity consideration and imply massive potential share issuance.ANALYZED 10:51 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 10:49 ET
LAST2.84DAY▲ 170.5%5 MIN▲ 17.37%5M RVOL11516×5M $VOL$16.0MFLOAT*2.5MRANK#1SESSIONREGULARVWAP2.01HOD2.84LOD0.9131OR HIGH2.09OR LOW1.62PREV CLOSE1.05PM HIGH2.53PM LOW0.9131GAP▲ 64.76%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $1.73, +64.8% on the previous close of $1.05
- 09:43 ETRegular-session low, $1.51
- 10:48 ETHalted (LUDP); resumed 10:53 ET, after 5 minutes
- 12:14 ETHalted (LUDP); resumed 12:19 ET, after 5 minutes
- 12:19 ETRegular-session high, $4.32
- 15:59 ETLast trade of the regular session, $3.03, +188.6% on the previous close of $1.05
- Volume: 169.5M shares in regular hours, 69.1M before the open
TCRT opened at $1.73 after an early unexplained move, then fell to $1.51 before surging to $2.84 when TapeRank recorded a halt at 10:49 ET. TapeRank tied the move to the announcement that Alaunos had completed its acquisition of Velaris Therapeutics, noting that the transaction involved securities convertible into roughly 138.3 million common shares and therefore substantial potential dilution; the stock resumed after five minutes, halted again at 12:14 ET, and reached a $4.32 high when it resumed at 12:19 ET. It ended the regular session at $3.03, up 188.6% from the previous close.
WRITTEN THU OCT 15 2026 18:05 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 09:28 ET8-K — Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Departure or Election of Directors or Officers; Amendments to Articles of Incorporation or Bylaws; Regulation FD Disclosure; Financial Statements and ExhibitsSEC 8-K
- 07:09 ETAlaunos Therapeutic Announced Completion Of Acquisition Of Velaris TherapeuticsBenzinga
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list